Javascript must be enabled to continue!
The Bourque Distances for Mutation Trees of Cancers
View through CrossRef
AbstractMutation trees are rooted trees of arbitrary node degree in which each node is labeled with a mutation set. These trees, also referred to as clonal trees, are used in computational oncology to represent the mutational history of tumours. Classical tree metrics such as the popular Robinson–Foulds distance are of limited use for the comparison of mutation trees. One reason is that mutation trees inferred with different methods or for different patients usually contain different sets of mutation labels. Here, we generalize the Robinson–Foulds distance into a set of distance metrics called Bourque distances for comparing mutation trees. A connection between the Robinson–Foulds distance and the nearest neighbor interchange distance is also presented.
Title: The Bourque Distances for Mutation Trees of Cancers
Description:
AbstractMutation trees are rooted trees of arbitrary node degree in which each node is labeled with a mutation set.
These trees, also referred to as clonal trees, are used in computational oncology to represent the mutational history of tumours.
Classical tree metrics such as the popular Robinson–Foulds distance are of limited use for the comparison of mutation trees.
One reason is that mutation trees inferred with different methods or for different patients usually contain different sets of mutation labels.
Here, we generalize the Robinson–Foulds distance into a set of distance metrics called Bourque distances for comparing mutation trees.
A connection between the Robinson–Foulds distance and the nearest neighbor interchange distance is also presented.
Related Results
The Bourque Distances for Mutation Trees of Cancers
The Bourque Distances for Mutation Trees of Cancers
Abstract
Background: Mutation trees are rooted trees in which nodes are of arbitrary degree are labeled with a mutation set. These trees, also referred to as clonal trees, ...
JAK2 Mutation in Granulocytes and Platelets and X-Chromosome Gene-Based Clonal Analysis in Chronic Myeloproliferative Disorders.
JAK2 Mutation in Granulocytes and Platelets and X-Chromosome Gene-Based Clonal Analysis in Chronic Myeloproliferative Disorders.
Abstract
BCR/ABL-negative chronic myeloproliferative disorders (CMPDs) are considered to arise in a pluripotent progenitor cell. High prevalence of a point mutation ...
Mutation in homologous recombination to predict a better prognosis in endometrial cancer.
Mutation in homologous recombination to predict a better prognosis in endometrial cancer.
6082 Background: Endometrial cancers have been categorized into four genomic classes by The Cancer Genome Atlas Research Network (TCGA) with comprehensive genomic analysis. Howeve...
Early-Onset Gastrointestinal Cancers
Early-Onset Gastrointestinal Cancers
ImportanceEarly-onset gastrointestinal (GI) cancer is typically defined as GI cancer diagnosed in individuals younger than 50 years. The incidence of early-onset GI cancer is risin...
Relationships of BRAF V600E Gene Mutation With Some Immunohistochemical Markers and Recurrence Rate in Patients With Thyroid Carcinoma
Relationships of BRAF V600E Gene Mutation With Some Immunohistochemical Markers and Recurrence Rate in Patients With Thyroid Carcinoma
Background:
The B-type rafkinase (BRAF) V600E gene mutation plays an important role in the pathogenesis, diagnosis, and prognosis of thyroid carcinoma. This stu...
CEBPA Gene Different Mutants Play Distinct Impacts On Tumor Suppressor Function Of C/EBP-Alpha and Bone Marrow Stromal Cells
CEBPA Gene Different Mutants Play Distinct Impacts On Tumor Suppressor Function Of C/EBP-Alpha and Bone Marrow Stromal Cells
Abstract
Introduction
CEBPA gene encodes CCAAT/enhancer-binding protein-alpha (C/EBPα), a crucial granulocytic differentiation f...
Analysis of Clinicopathologic Factors and KRAS Gene Mutation in Epithelial Ovarian Cancer Outcomes
Analysis of Clinicopathologic Factors and KRAS Gene Mutation in Epithelial Ovarian Cancer Outcomes
BACKGROUND: Raise of ovarian cancer mortality is caused by high ovarian cancer recurrence. This is related to many prognostic factors. Kirsten-rat sarcoma virus oncogene (KRAS) is ...
Estrogen Rececptor (ER)-Positive Breast Cancers in BRCA1 Mutation Carriers: Mutation-Related or Sporadic?
Estrogen Rececptor (ER)-Positive Breast Cancers in BRCA1 Mutation Carriers: Mutation-Related or Sporadic?
Abstract
Background: Most invasive breast cancers (IBC) in BRCA1 mutation carriers are ER negative (-) and have a basal-like phenotype by expression array analysis. ...

